stockrow
Friday 6 November 2026
Export CV’s income statement to Excel — free account
CapsoVision, Inc.
CapsoVision, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $13.6 million, up 15.3% from fiscal 2024.
- Revenue
- +9.89%
- EPS
- +92.6%
- Free cash flow
- −84.4%
Quarter to June 2026, against a year earlier
6.33
0.13
+2.10%
Follow CV
Alert me
| Dec '25 | Dec '24 | |
|---|---|---|
P/E ratio |
0.00 | 0.00 |
Altman Z-Score |
17.04 | — |
P/S ratio |
19.37 | 0.67 |
Altman Z″-Score (non-manufacturers) |
(30.12) | (29.09) |
P/FCF ratio |
0.00 | 0.00 |
Beneish M-Score |
(3.47) | — |
P/Operating CF |
(34.15) | (1.77) |
P/B ratio |
19.80 | 0.00 |
Price to Tangible BV |
19.80 | 0.00 |
EV/Sales |
18.62 | 0.58 |
EV/EBITDA |
0.00 | 0.00 |
EV/Operating CF |
(11.04) | (0.32) |
EV/FCF |
(11.00) | (0.32) |
Quick Ratio |
2.85 | 6.29 |
Current Ratio |
3.77 | 8.24 |
Net Debt/EBITDA |
0.41 | 0.48 |
Debt/Assets |
0.00% | 0.00% |
Debt/Equity |
0.00 | 0.00 |
Asset Turnover |
0.78 | 0.00 |
Operating CF/Net income |
0.90 | 1.01 |
Capex/Depreciation |
(0.16) | (0.29) |
| 43.55% | 0.00% | |
| (144.79%) | 0.00% | |
ROIC |
(506.59%) | 0.00% |
Return on Tangible Assets |
(196.96%) | (144.54%) |
Average Days of Receivables |
67.27 | 62.13 |
Research and Development Expense of Revenue |
135.09% | 128.62% |
Selling, General and Administrative Expense of Revenue |
106.09% | 95.05% |
Intangible Assets out of Total Assets |
0.00 | 0.00 |
Share Based Compensation of Revenue |
6.09% | 1.33% |
Graham Net Nets |
0.04 | (17.54) |
Graham Number |
0.00 | 0.00 |
Earnings Yield |
(45.24%) | (282.26%) |
Free Cash Flow Yield |
(8.74%) | (274.76%) |
Revenue per Share |
0.55 | 5.82 |
Operating CF per Share |
(0.93) | (9.95) |
Capex per Share |
0.00 | (0.08) |
Free Cash Flow per Share |
(0.93) | (10.02) |
Cash per Share |
0.41 | 4.61 |
Shareholders Equity per Share |
0.54 | (64.11) |
Interest Debt per Share |
0.00 | 0.00 |
Book value per Share |
0.54 | (64.11) |
Free Cash Flow |
(22.95) | (20.24) |
Working Capital |
12.24 | 13.05 |
Capital Expenditures |
(0.09) | (0.15) |
Net Current Asset Value |
11.77 | (131.47) |
EV/EBIT |
0.00 | 0.00 |
Capex to Sales |
0.01 | 0.01 |
Price to Operating Income |
0.00 | 0.00 |
| Other line items | ||
Depreciation/Fixed assets |
0.93 | 0.72 |
Cash ROIC |
(98.21%) | 16.84% |
Accounts Receivable Turnover |
6.03 | 0.00 |
Accounts Payable Turnover |
6.75 | 0.00 |
Inventory Turnover |
2.27 | 0.00 |
Average Days of Payables |
65.38 | 50.82 |
Days of Inventory on Hand |
170.86 | 178.39 |
Average Receivables |
2.25 | — |
Average Payables |
0.95 | — |
Average Inventory |
2.81 | — |
Average Assets |
17.48 | — |
Average Common Equity |
(58.12) | — |
Columns are period end dates · fundamentals updated 26 Oct 2026